Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ligand Pharmaceuticals Ownership Summary


Ligand Pharmaceuticals is owned by 43.66% institutional investors, 2.39% insiders, and 53.95% retail investors. Tudor investment corp et al is the largest institutional shareholder, holding 81.78% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.99% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLigand Pharmaceuticals43.66%2.39%53.95%
SectorHealthcare Stocks 35.74%11.83%52.43%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tudor investment corp et al15.75M81.78%$17.70M
Blackrock2.87M16.19%$241.95M
Blackrock funding, inc. /de2.96M15.02%$591.35M
Vanguard group2.07M10.71%$392.11M
Janus henderson group1.01M5.12%$201.62M
Invesco823.60K4.18%$164.43M
State street778.86K3.95%$155.50M
Fmr596.13K3.02%$119.02M
Macquarie management573.31K2.91%$114.46M
Franklin resources573.18K2.91%$114.43M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ashford capital management207.56K5.12%$41.44M
Villere st denis j188.87K4.16%$37.71M
Private capital management201.38K4.00%$40.21M
Ranger investment management267.94K3.87%$53.49M
Rice hall james & associates283.57K3.15%$56.61M
Cardinal capital management llc /ct133.67K3.08%$11.26M
Chicago capital561.67K3.02%$112.14M
Lisanti capital growth38.61K1.94%$7.71M
Essex investment management58.46K1.85%$11.67M
Penn capital management company95.46K1.48%$19.08M

Top Buyers

HolderShares% AssetsChange
Tudor investment corp et al15.75M0.03%15.75M
Invesco823.60K0.03%307.14K
Vanguard fiduciary trust127.90K0.01%127.90K
Next century growth investors95.88K1.39%95.88K
Bessemer group107.86K0.03%84.35K

Top Sellers

HolderShares% AssetsChange
Macquarie group---751.79K
Cardinal capital management llc /ct133.67K3.08%-425.56K
William blair investment management---205.69K
Ubs asset management americas212.89K0.01%-150.70K
Jacobs levy equity management20.53K0.02%-106.22K

New Positions

HolderShares% AssetsChangeValue
Tudor investment corp et al15.75M0.03%15.75M$17.70M
Vanguard fiduciary trust127.90K0.01%127.90K$25.54M
Next century growth investors95.88K1.39%95.88K$19.14M
Norges bank46.29K0.00%46.29K$4.96M
Palisade capital management, lp20.52K0.14%20.52K$4.10M

Sold Out

HolderChange
Dv trading-1.00
Flagship harbor advisors-1.00
Td capital management-1.00
Mendota financial group-1.00
Cgc financial services-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026218-38.24%8,612,118-58.08%430.39%107-40.56%69-39.47%
Dec 31, 2025275-12.97%15,606,007-23.88%800.71%137-16.97%91-8.08%
Sep 30, 202530215.71%36,213,42492.32%1881.97%16315.60%887.32%
Jun 30, 20252662.31%19,162,9152.69%991.05%14410.77%82-5.75%
Mar 31, 2025258-1.53%18,645,9442.31%970.99%128-15.23%8846.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.20M5.99%255.00
Delaware Small Cap Core I655.86K3.59%-57.44K
Macquarie Small Cap Core I670.37K3.44%-14.18K
Janus Henderson US SMID Cap Growth MA596.82K3.09%596.78K
Vanguard Total Stock Mkt Idx Inv596.89K2.98%1.97K
Vanguard US Total Market Shares ETF529.85K2.75%-
Franklin DynaTech A550.00K2.74%25.00K
Franklin Innovation Composite525.00K2.65%75.00K
Janus Henderson Triton D486.18K2.43%-11.88K
Janus Henderson US SMID Cap Growth486.18K2.43%-44.71K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 16, 2026Sabba Stephen L-Sell$544.83K
Jun 12, 2026Haas Jason-Sell$886.29K
Jun 12, 2026Haas Jason-Sell$765.03K
Jun 11, 2026Aryeh Jason-Sell$1.13M
Jun 10, 2026Aryeh Jason-Sell$125.00K

Insider Transactions Trends


DateBuySell
2026 Q2-41
2026 Q1-42
2025 Q4-18
2025 Q3-8
2025 Q253

LGND Ownership FAQ


Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 43.66%, followed by 2.39% insiders and 53.95% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 36.05%, which Ligand Pharmaceuticals exceeds.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Tudor investment corp et al (15.75M shares, 81.78%), Blackrock (2.87M shares, 16.19%), and Blackrock funding, inc. /de (2.96M shares, 15.02%). Together, they hold 112.99% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.12% of its assets in 207.56K Ligand Pharmaceuticals shares, valued at 41.44M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 5.99% of its total shares outstanding invested in 1.2M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools